Navigation Links
Brookdale Announces Completion of Follow-On Offering
Date:6/8/2009

orward-looking information. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Although we believe that the expectations reflected in such forward-looking statements are based on reasonable assumptions, actual results and performance could differ materially from those set forth in the forward-looking statements. Factors which could have a material adverse effect on our operations and future prospects or which could cause events or circumstances to differ from these forward-looking statements include, but are not limited to, the risk associated with the current global economic crisis and its impact upon capital markets and liquidity; our inability to extend (or refinance) debt as it matures or replace our amended credit facility when it matures; the risk that we may not be able to satisfy the conditions precedent to exercising the extension options associated with certain of our debt agreements; events which adversely affect the ability of seniors to afford our monthly resident fees or entrance fees; the conditions of housing markets in certain geographic areas; our ability to generate sufficient cash flow to cover required interest and long-term operating lease payments; the effect of our indebtedness and long-term operating leases on our liquidity; the risk of loss of property pursuant to our mortgage debt and long-term lease obligations; the possibilities that changes in the capital markets, including changes in interest rates and/or credit spreads, or other factors could make financing more expensive or unavailable to us; the risk that we may be required to post additional cash collateral in connection with our interest rate swaps; the risk that continued market deterioration could jeopardize certain of our counterparties' obligations; changes in governmental reimbursement programs; our limited operating history on a combined basis; our ability to effectively manage our growth; our ability to maintain cons
'/>"/>
SOURCE Brookdale Senior Living Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Brookdale to Present at JMP Securities Research Conference
2. Brookdale to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
3. Brookdale Announces First Quarter 2009 Results; CFFO of $0.49 per Share
4. Brookdale Announces First Quarter 2009 Release and Earnings Call
5. Brookdale to Present at Barclays Capital Global Healthcare Conference March 11
6. Brookdale Announces Fourth Quarter and Full Year 2008 Results
7. Brookdale Amends and Extends Corporate Line of Credit
8. Brookdale Announces Fourth Quarter 2008 Release and Earnings Call
9. Brookdale to Present at UBS Global Healthcare Services Conference February 10
10. AT&T Mobility and Brookdale Senior Living Host First Cell Phones for Seniors Public Service Event in New York City
11. Brookdale Announces Second Quarter 2008 Release and Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 Urban Hydroponics, ... “Company”) today announced it has signed a Binding Letter ... in the urban cultivation sector - Urban Cultivator Inc. ... Lights”), and W3 Metal Inc. (“W3 Metal” and together ... Companies”). Pursuant to the LOI and an earlier ...
(Date:10/31/2014)... 31, 2014 Triple Board Certified surgeon ... restoration services to transform the appearance of military veteran ... Academy of Facial Plastic and Reconstruction Surgery (AAFPRS) Faces ... restore the facial hair Jones lost during an IED ... pro-bono hair restoration procedure, valued around $16,000, took Dr. ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Med-Care Diabetic ... on the highest principles of patient care and service, ... leading health and wellness website, to provide an online ... diabetes. , The Diabetes Health Center will provide ... for those living with diabetes. Content will feature advice ...
(Date:10/31/2014)... Dennis Thompson HealthDay Reporter ... full-court press involving all public health tactics known to ... current West African epidemic, a new study reports. ... in a hygienic way, immediately isolating new patients, tracing ... protection for health care workers -- can stop the ...
(Date:10/31/2014)... Alan Mozes HealthDay Reporter ... the world of 21st-century medicine, organ transplantation is nothing new. ... by the first liver transplant in 1963 and the first ... managed the transplantation of a patient,s entire face. One ... human eye. But if one team of U.S. scientists has ...
Breaking Medicine News(10 mins):Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 2Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 3Health News:Scientists Set Their Sights on First Whole-Eye Transplant 2Health News:Scientists Set Their Sights on First Whole-Eye Transplant 3
... is available in French . Montreal, November ... the marketplace, thanks to a new partnership between Gestion ... a privately owned technology company based in Montreal. ... and its affiliated institutions, and CSI have announced the ...
... Nov. 25, 2009 Physicians at UT Southwestern Medical Center ... breathing in patients with upper spinal-cord injuries or other diseases ... University Hospital St. Paul is only one of only ... country currently equipped to implant the device, called the NeuRx ...
... success for patients with liver lesions, researchers find , ... cetuximab to neoadjuvant chemotherapy can shrink tumors and boost ... with inoperable metastatic liver lesions, new research suggests. ... the body in more than half of patients with ...
... Two experts offer waistline-friendly ways to enjoy festive feasting , ... five-week holiday smorgasbord from Thanksgiving to New Year,s, but are ... off come Jan. 1, help is at hand. , It,s ... make it to 2010 weighing the same as you ...
... ... natural treatments to complement conventional methods. , ... Burnaby, BC (Vocus) November 25, 2009 -- While surgery, chemotherapy ... turn to alternative medicine to help them cope with the side effects of conventional ...
... ... a new market research report is available in its ... (2nd Edition) , http://www.reportlinker.com/p0165301/The-Market-for-Anti-ageing-Foods-(2nd-Edition ).html , ... a fast pace with growth outstripping that of conventional ...
Cached Medicine News:Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Holistic and Western Medicine Combined Can Fight Cancer 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 7
(Date:10/31/2014)... AUSTIN, Texas , Oct. 31, 2014 /PRNewswire/ ... 3D holographic visualization technologies announced today a strategic ... industry leader in high-end 3D anatomy and biomedical ... the medical and medical education markets.  Zygote maintains ... anatomy and biomedical models and has pioneered development ...
(Date:10/31/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP)( ... the development of oral drug delivery systems, announces ... to discuss the clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes ... Eastern time. Shareholders and other interested ...
(Date:10/31/2014)...  Zacks.com announces the list of stocks featured in the Analyst ... news and events impacting stocks and the financial markets. Stocks recently ... - Free Report ), Celgene (Nasdaq: CELG - ... Free Report ), Market Vectors Biotech ETF (AMEX: BBH ... XBI - Free Report ). Today, ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
... May 3, 2012 Cardinal Health today reported a 3 ... and a 6 percent increase in non-GAAP operating earnings to ... in non-GAAP diluted earnings per share (EPS) from continuing operations ... solid quarter of revenue growth for both of our business ...
...  Cara Therapeutics, Inc. and Chong Kun Dang Pharmaceutical Corporation ... a licensing agreement that provides CKD Pharm with the ... drug candidate, CR845, in the Republic of Korea.  Under ... up-front payment, including an equity investment, and is eligible ...
Cached Medicine Technology:Cardinal Health Reports Third-Quarter Results 2Cardinal Health Reports Third-Quarter Results 3Cardinal Health Reports Third-Quarter Results 4Cardinal Health Reports Third-Quarter Results 5Cardinal Health Reports Third-Quarter Results 6Cardinal Health Reports Third-Quarter Results 7Cardinal Health Reports Third-Quarter Results 8Cardinal Health Reports Third-Quarter Results 9Cardinal Health Reports Third-Quarter Results 10Cardinal Health Reports Third-Quarter Results 11Cardinal Health Reports Third-Quarter Results 12Cardinal Health Reports Third-Quarter Results 13Cardinal Health Reports Third-Quarter Results 14Cardinal Health Reports Third-Quarter Results 15Cardinal Health Reports Third-Quarter Results 16Cardinal Health Reports Third-Quarter Results 17Cardinal Health Reports Third-Quarter Results 18Cardinal Health Reports Third-Quarter Results 19Cardinal Health Reports Third-Quarter Results 20Cardinal Health Reports Third-Quarter Results 21Cardinal Health Reports Third-Quarter Results 22Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market 2Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market 3
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
VACUETTE PaediatricMulti-Sample Needle...
... Blood Collection Needles are preominantly used for ... single-use. The colour of the needle protective ... needle gauges. For example, yellow symbolises the ... 21 G (0.80 mm) and black 22 ...
This is adapted to microplate or card....
Medicine Products: